Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Old API Wind-down Ltd - Ordinary Shares ARLZQ

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven


OTCPK:ARLZQ - Post by User

Old API Wind-down Ltd - Ordinary Shares > Picks like ARZ come around very rarely
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by GoldenDilemmaon Mar 21, 2017 11:29am
83 Views
Post# 26007949

RE:RE:RE:RE:RE:RE:RE:RE:RE:Picks like ARZ come around very rarely

RE:RE:RE:RE:RE:RE:RE:RE:RE:Picks like ARZ come around very rarely
Systemtogo wrote: Management weren't buying all the way. You can refer to the following chart to see when they
bought. I'm not basing my philosophy on ARZ, I'm basing on every pick I see that follows this system. AUP wasn't an anomoly, it's the usual. As well, ARZ went up to over $8. No stock ever goes up in a straight line. Again refer to the chart and see the significant upwings ARZ has been through in the last year. Only time will tell who's correct though right... 

 https://www.canadianinsider.com/company?ticker=ARZ


No comparison between ARLZ and AUP.

The latter does R&D. The former has debt and a drug portfolio shorts deem worthless. But, again, fundamentals don't matter, right? 

ARLZ market cap is currently worth less than what they paid for Toprol XL. What message does that send to you? Think it was the longs who sent that message?? 

I do not care about insider buys; nor do the shorts.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities